Campaigners have blasted the move as a "major disappointment”.

“Pothead” could one day get a whole new meaning. A new study suggests low doses of THC, the main psychoactive ingredient in ...

Biogen Inc. (NASDAQ:BIIB) on Friday reported better-than-expected fourth-quarter earnings, with adjusted EPS of $1.99, ...

A mathematical model simulated patient outcomes when given caregiver support or an expensive Alzheimer’s drug to determine cost and health benefits.

A global expert review has identified a shingles vaccine and two existing drugs as leading candidates for repurposing against ...

A UCSF study found that a "collaborative care" model for dementia patients improved quality of life, reduced costs, alleviated caregiver burden, and extended the time that patients remained in the ...

Programs that match caregivers with patient navigators yield better outcomes than Alzheimer's drug – but combining the two ...

Experts see shift toward tailored cancer therapy model Lilly awaiting details of Novo's failed trial Some drug developers target multiple biomarkers Sign up here. Globally, over 55 million people have ...

China granted Priority Review for an at-home Alzheimer’s treatment developed by Biogen and Eisai. ・If approved, the ...

Patients with dementia who participated in a Medicare-funded collaborative care program that provided support and medical advice for caregivers were able to remain in their home communities longer ...

From Science.org. "T3D Therapeutics alleges that contract researchers delivered “medically impossible” results on its candidate drug. In 2023, the drug ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A scientist looks at hypometabolic and hypoperfusion patterns at the single-subject level from a patient suffering ...